Evidence map›Paper›PMID 42397682›Full record

ArticleEpilepsia open2026

Expanding the electroclinical spectrum of TANC2-related disorders: Lennox-Gastaut syndrome and related developmental epileptic phenotypes.

Lorenzo Perilli, Carlotta Stipa, Gianmichele Villano, Laura Licchetta, Leo Strothmann, Robin Tobias Jauss, Gerhard Josef Kluger, Raffaella Minardi, NETRE consortium, Giuseppe Gobbi and 3 more

Abstract read
In one paragraph

Article in Epilepsia open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lorenzo PerilliClinical Pediatrics, Department of Molecular Medicine and Development, Azienda Ospedaliero-Universitaria Senese, University of Siena, Siena, Italy.ORCID https://orcid.org/0000-0002-8630-6718
Carlotta StipaIRCCS Istituto Delle Scienze Neurologiche di Bologna, European Reference Network for Rare and Complex Epilepsies (EpiCARE), Bologna, Italy.ORCID https://orcid.org/0000-0001-7628-3711
Gianmichele VillanoDepartment of Neurosciences Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.ORCID https://orcid.org/0009-0009-5189-2161
Laura LicchettaIRCCS Istituto Delle Scienze Neurologiche di Bologna, European Reference Network for Rare and Complex Epilepsies (EpiCARE), Bologna, Italy.ORCID https://orcid.org/0000-0001-7979-9895
Leo StrothmannDepartment of Pediatric Neurology, Hospital Kassel, Kassel, Germany.
Robin Tobias JaussUniversity of Leipzig Medical Center, Institute of Human Genetics Philipp-Rosenthal-Straße 55, Leipzig, Germany.ORCID https://orcid.org/0000-0002-8285-9155
Gerhard Josef KlugerChildren Hospital, Research Institute Rehabilitation, Transition and Palliation", PMU Salzburg, Salzburg, Austria.
Raffaella MinardiIRCCS Istituto Delle Scienze Neurologiche di Bologna, European Reference Network for Rare and Complex Epilepsies (EpiCARE), Bologna, Italy.ORCID https://orcid.org/0000-0002-8190-8517
NETRE consortium
Giuseppe GobbiAssociazione Famiglie LGS Italia, Correggio, Italy.
Salvatore GrossoClinical Pediatrics, Department of Molecular Medicine and Development, Azienda Ospedaliero-Universitaria Senese, University of Siena, Siena, Italy.ORCID https://orcid.org/0000-0002-0974-0596
Francesca BisulliIRCCS Istituto Delle Scienze Neurologiche di Bologna, European Reference Network for Rare and Complex Epilepsies (EpiCARE), Bologna, Italy.ORCID https://orcid.org/0000-0002-1109-7296
Pasquale StrianoDepartment of Neurosciences Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.ORCID https://orcid.org/0000-0002-6065-1476

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveNeurodevelopmental disorders (NDDs) and epilepsy are often associated. Increasing evidence highlights a pivotal role for pathogenic variants in genes encoding synaptic scaffolding proteins. Within this group, TANC2 has recently been implicated in intellectual developmental disorder with autistic features and language delay, with or without seizures; however, its full clinical spectrum and contribution to specific epileptic encephalopathies remain incompletely defined.

methodsWe describe the electroclinical and developmental features of three patients carrying truncating TANC2 variants identified through trio-exome sequencing within the European collaborative platform NETRE. Clinical, neuropsychological, and EEG data were collected and compared with prior reports.

resultsCase #1 met Lennox-Gastaut syndrome (LGS) criteria, showing early drug resistance followed by partial cognitive recovery and sustained seizure control on felbamate monotherapy. Case #2 presented with ASD and multiple seizure types-including focal, atypical absence, and tonic-finally reaching prolonged remission and borderline intellectual functioning. Case #3 showed early-onset, drug-resistant polymorphic seizures with persistent bifrontal epileptiform discharges and severe developmental impairment, consistent with an LGS-like phenotype, with seizure freedom achieved under a limited polytherapy regimen. SIGNIFICANCE: Our findings expand the electroclinical spectrum of TANC2-related disorders, supporting a continuum ranging from NDD-associated epilepsy to DEE, including LGS in selected patients. PLAIN LANGUAGE SUMMARY: TANC2 is a gene involved in brain development and synaptic function. Changes in this gene have been linked to neurodevelopmental disorders, autism, intellectual disability, and epilepsy. We describe three individuals with previously unreported truncating TANC2 variants and different epilepsy phenotypes, including one patient fulfilling criteria for Lennox-Gastaut syndrome (LGS) and another with LGS-like features. Although seizures were initially difficult to treat in some cases, seizure control was eventually achieved. These findings expand the known clinical spectrum of TANC2-related disorders and suggest that selected patients may have a more favorable seizure course than expected.

Indexed as

epilepsyLennox–Gastaut syndromeneurodevelopmental disordersprecision medicinesynaptopathyTANC2trio‐exome sequencing

Identifiers

PMID42397682
PMCPMC13394827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.